NIH #R43GM154542
Chemically Induced Dimerization Systems for High Throughput Enzyme Assays
- Amount
- $200K–$300K
- Period
- 2024-09-20 → 2026-06-19
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R21AI160508
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
- Amount
- $300K–$400K
- Period
- 2021-08-01 → 2024-07-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44AI141281
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
- Amount
- $900K–$1000K
- Period
- 2019-06-12 → 2023-01-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43CA254590
Discovery of TREX1 Antagonists for Cancer Immunotherapy
- Amount
- $300K–$400K
- Period
- 2020-09-11 → 2022-05-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43AI141281
Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases
- Amount
- $300K–$400K
- Period
- 2019-06-12 → 2021-02-16
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44GM123833
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $500K–$600K
- Period
- 2017-05-01 → 2020-04-30
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R41GM121123
Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers
- Amount
- $200K–$300K
- Period
- 2016-09-13 → 2019-03-31
- PIs
- 2
Awarded at BELLBROOK LABS, LLC
NIH #R43AA025498
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis
- Amount
- $300K–$400K
- Period
- 2016-09-20 → 2018-08-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43GM123833
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
- Amount
- $200K–$300K
- Period
- 2017-05-01 → 2018-04-30
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44GM109621
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
- Amount
- $400K–$500K
- Period
- 2014-07-15 → 2018-04-30
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R41NS090693
Axonal Transport HTS Platform for Neurodegeneration Drug Discovery
- Amount
- $200K–$300K
- Period
- 2015-06-01 → 2017-05-31
- PIs
- 2
Awarded at BELLBROOK LABS, LLC
NIH #R43NS089394
Fluorescent biosensors for dynamic monitoring of paracrine signaling in extracellular matrix
- Amount
- $200K–$300K
- Period
- 2015-04-01 → 2016-12-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #K12HL108974
Oregon Multidisciplinary Training Program in Emergency Medicine Clinical Research
- Amount
- $500K–$600K
- Period
- 2011-07-01 → 2016-06-30
- PIs
- 1
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #R43GM109621
Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery
- Amount
- $200K–$300K
- Period
- 2014-07-15 → 2016-01-14
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R15GM075960
Mechanism Based Design of Ce(IV) Mediated Reactions
- Amount
- $300K–$400K
- Period
- 2006-02-02 → 2015-08-14
- PIs
- 1
Awarded at LEHIGH UNIVERSITY
NIH #C
Replicating Tumor ECM in Microchannels for 3D Phenotypic HTS Assays
- Amount
- $200K–$300K
- Period
- 2014-09-12 → 2015-06-11
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44HL103079
Screening Device for Differentiated Primary Cell Models of Airway Epithelia
- Amount
- $500K–$600K
- Period
- 2010-04-01 → 2014-07-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #RC4DA029988
Building an Evidence Base for Treating the Vulnerable: A Community Partnership
- Amount
- $400K–$500K
- Period
- 2010-09-30 → 2013-09-29
- PIs
- 1
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #R43GM101771
High Throughput Assay for Detecting Protein Modifications in Cell Lysates
- Amount
- $200K–$300K
- Period
- 2011-09-26 → 2013-09-25
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43GM095124
Intramolecular Immunoassay for Probing Paracrine Signaling
- Amount
- $200K–$300K
- Period
- 2010-09-01 → 2012-08-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #U10NS058940
Brain Research/Acute Interventions: Neurological Emergencies Treatment Trials
- Amount
- $300K–$400K
- Period
- 2007-09-30 → 2012-08-31
- PIs
- 1
Awarded at OREGON HEALTH & SCIENCE UNIVERSITY
NIH #R44NS059082
HTS Assays for Modulators of GPCR Signaling
- Amount
- $700K–$800K
- Period
- 2007-09-01 → 2011-11-28
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44GM073290
Fluorescent HTS Assays for Methyltransferases in Neurodegenerative Diseases
- Amount
- $400K–$500K
- Period
- 2006-09-15 → 2011-07-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43GM088945
Enhanced ADP Immunoassay for Multimode Kinase Detection
- Amount
- $100K–$200K
- Period
- 2009-08-01 → 2011-01-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43GM083478
Generic Fluorescent HTS Assay for Oxidoreductases
- Amount
- $200K–$300K
- Period
- 2008-02-01 → 2009-01-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44CA110535
Generic Fluorescent HTS Assay for Kinases and ATPases
- Amount
- $300K–$400K
- Period
- 2005-07-01 → 2008-09-29
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43NS059082
HTS Assays for Modulators of GPCR Signaling
- Amount
- $200K–$300K
- Period
- 2007-09-01 → 2008-08-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R43GM073290
Fluorescent HTS Assay for Methyltransferases in Neurodegenerative Diseases
- Amount
- $100K–$200K
- Period
- 2006-09-15 → 2007-06-30
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NIH #R44GM069258
Fluorescent HTS Assays for Human Sulfotransferases
- Amount
- $400K–$500K
- Period
- 2003-07-01 → 2007-05-31
- PIs
- 1
Awarded at BELLBROOK LABS, LLC
NSF #8319802
North Carolina School For Science and Mathematics TelevisionPresentation on the Study of Science and Math
- Amount
- <$100K
- Period
- 1983-09-01 → 1984-08-31
- PIs
- 1
Awarded at Department of Defense Information Systems Agency